000 01340 a2200433 4500
005 20250513122322.0
264 0 _c19970909
008 199709s 0 0 eng d
022 _a1087-0156
024 7 _a10.1038/nbt0797-632
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHolliger, P
245 0 0 _aRetargeting serum immunoglobulin with bispecific diabodies.
_h[electronic resource]
260 _bNature biotechnology
_cJul 1997
300 _a632-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntibodies, Bispecific
_xblood
650 0 4 _aAntigens
650 0 4 _aBase Sequence
650 0 4 _aBiotechnology
650 0 4 _aComplement System Proteins
_xmetabolism
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aDNA Primers
_xgenetics
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aImmunization, Passive
650 0 4 _aImmunoglobulins
_xblood
650 0 4 _aMuramidase
_ximmunology
650 0 4 _aPhagocytosis
650 0 4 _aReceptors, IgG
_xmetabolism
650 0 4 _aTumor Cells, Cultured
700 1 _aWing, M
700 1 _aPound, J D
700 1 _aBohlen, H
700 1 _aWinter, G
773 0 _tNature biotechnology
_gvol. 15
_gno. 7
_gp. 632-6
856 4 0 _uhttps://doi.org/10.1038/nbt0797-632
_zAvailable from publisher's website
999 _c9199566
_d9199566